# POMALIDOMIDE
> **ANDA210111** · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2020-10-30
## Drug
- **FDA Application Number:** ANDA210111
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POMALIDOMIDE
- **Generic name:** POMALIDOMIDE
- **Active ingredients:** POMALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRECKENRIDGE
- **Manufacturer:** Natco Pharma Limited
- **First approval:** 2020-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210111)
---
*MORVS · CC0 1.0*